1. At a Glance – The Extract King With a Working Capital Hangover
AVT Natural Products Ltd is sitting at a market cap of ₹1,002 Cr, trading at ₹65.8 per share, with a P/E of 17.5 and dividend yield of 1.06%. Sounds decent, right? Now zoom in.
Q3 FY26 revenue came in at ₹194 Cr, up 12.2% YoY. PAT stood at ₹17.4 Cr. OPM is hovering around 12%. ROCE is 12.8%. ROE is 9.89%.
But here’s the masala: inventory days have ballooned to 431 days. Debtor days are 103. Debt is ₹100 Cr. Cash conversion cycle? A royal 388 days.
Three-month return: -7.76%. Six-month return: -8.14%.
So the stock is not exactly in a Diwali rally.
This is a company exporting natural extracts to the world, supplying long-term global clients, investing in R&D, launching new verticals… and yet the balance sheet is screaming, “Bhai, capital ka kya kar rahe ho?”
Is this a patient long-term compounding story or a plant-based working capital experiment?
Let’s dig.
2. Introduction – From Kerala Fields to Global Formulations
AVT Natural is part of the A.V. Thomas Group – an old-school South Indian business house with tea estates, plantations, and agriculture roots.
They manufacture plant-based extracts used in:
- Food colouring
- Eye-care supplements
- Poultry pigmentation
- Nutraceuticals
- Tea extracts
- Spice oils
Basically, if your capsule, seasoning, or instant tea has something “natural” written on it, there’s a chance AVT had a hand in it.
But the last few years haven’t been a smooth herbal infusion.
Between FY22 and FY24, total revenue declined 8%. The culprit? Marigold oleoresin segment faced El Niño weather disruption and Chinese competition backed by government subsidies.
Yes. Climate + China. The deadly combo.
And here’s the concentration twist: Top 5 customers contribute 70–80% of revenue.
That’s not diversification. That’s dependency with a handshake.
Still confident? Or slightly nervous?
Let’s understand what they actually sell.
3. Business Model – WTF Do They Even Do?
AVT operates in the “Food & Feed Ingredients from Natural Raw Materials” segment.
Here’s the breakup:
1. Marigold Oleoresin (34% of FY24 revenue)
Used for:
- Eye care (lutein)
- Food colouring
- Poultry pigmentation
This segment fell from 42% in FY22 to 34% in FY24 due to weather issues and Chinese price war.
Basically, nature didn’t cooperate and China didn’t negotiate.
2. Spice Extracts (32%)
Spice oleoresins and oils used in flavouring and colouring. Stable contribution.
3. Tea (31%)
Value-added teas including decaffeinated and instant tea. This segment has grown from 22% in FY22 to 31% in FY24.
Tea is quietly becoming the new hero.
4. Others (3%)
Animal health, crop inputs.
They process 70,000 tons of plant material and 5,000 tons of extracts annually across facilities in Kerala and Karnataka.
They also operate a windmill generating 8,49,811 units of electricity in FY24, 95% used internally.
Plant extracts + wind energy. Very ESG-friendly vibes.
But vibes don’t pay interest costs.
Let’s see the numbers.
4. Financials Overview – The Quarter That Matters
Q1 FY26 EPS = ₹0.80
Q2 FY26 EPS = ₹0.87
Q3 FY26 EPS = ₹1.14
Average = (0.80 + 0.87 +
